<DOC>
	<DOCNO>NCT02025894</DOCNO>
	<brief_summary>The purpose study identify risk factor thromboembolic /or infectious complication 3,000 patient solid tumor receive Percutaneous Central Venous Catheter ( PCVC ) . A good understanding risk factor complication population would allow interventional study propose assess benefit prophylactic procedure sub-group patient risk .</brief_summary>
	<brief_title>Risk Factors Thromboembolic Infectious Complications Related Percutaneous Central Venous Catheters Cancer - Prospective Multicenter Study</brief_title>
	<detailed_description />
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<criteria>Patient neoplastic solid tumour indication insertion PCVC . Haematological neoplasm pathology , PCVC removal schedule within 2 week insertion , Therapeutic dos anticoagulant require inclusion , PCVC insert femoral vein</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>neoplastic solid tumour</keyword>
	<keyword>PCVC</keyword>
	<keyword>thromboembolic complication</keyword>
	<keyword>infectious complication</keyword>
	<keyword>risk factor</keyword>
</DOC>